Jeffrey Oelke
Jeff represents clients in patent litigation and other intellectual property issues, including some of the world's preeminent life sciences, pharmaceutical, biotech and high-tech companies. He has extensive experience guiding clients through all phases of complex patent litigation, including Hatch-Waxman patent litigation, inter partes reviews at the U.S. Patent Office and appeals to the U.S. Court of Appeals for the Federal Circuit.
Jeff has been lead counsel on several high-profile patent infringement disputes as well as arbitrations on patent licensing issues, and has achieved a string of significant victories for his clients. An important part of his practice is counseling his clients prior to litigation on issues concerning patentability, patent clearance and licensing. Jeff has also developed a significant track record litigating matters and counseling clients in the electrical arts, including mobile communications, internet applications, semiconductor devices and hardware and software inventions.
Jeff is one of the most experienced patent litigators in the field. He is a phenomenal trial attorney while at the same time able to explain difficult and scientific subjects to others. He is wonderful to work with."
- “Inequitable Conduct, Willful Infringement and Antitrust Law: Navigating New Challenges in Patent Litigation, The Impact of Recent Patent Law Cases and Development, Inside The Minds,” Thomson Reuters, 2013
- “Surviving the Patent Shakeup,” Chief Executive Magazine, July/August 2008
- "Addressing second medical use infringement," Life Sciences Patent Network North America, June 1, 2017
- "Intellectual Property Law and the Biosciences," The Stanford Law School Conference, April 27, 2012
- "Understanding the Recent Bankruptcy Court Decision Threatens Intellectual Property Rights of Licensees from Foreign Owners," Knowledge Congress, September 2011
- “Emerging Intellectual Property Issues For Attorneys: A 2009 Update," Knowledge Congress, May 2009